Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Grabner

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Ecology and Evolution|June 30, 2021
Looking for the needle in a downsized haystack: Whole-exome sequencing unravels genomic signals of climatic adaptation in Douglas-fir (<i>Pseudotsuga menziesii</i>)Jan-Peter George, Silvio Schueler, Michael Grabner, et al.
Journal of Managed Care & Specialty Pharmacy|November 1, 2022
Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United StatesLia N Pizzicato, Aisha Vadhariya, Julie Birt, et al.
Primary Care Diabetes|November 5, 2017
Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitusSamaneh Kalirai, Judith Stephenson, Magaly Perez-Nieves, et al.
The New Phytologist|April 23, 2009
Three centuries of insect outbreaks across the European AlpsUlf Büntgen, David Frank, Andrew Liebhold, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
Current Medical Research and Opinion|April 17, 2015
Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) studyEllen B Dennehy, Rebecca L Robinson, Judith J Stephenson, et al.
Clinical Rheumatology|June 7, 2022
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USATheresa Hunter, Michael Grabner, Julie Birt, et al.
Future Oncology (London, England)|August 19, 2024
Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USALiya Wang, Mukul Singhal, Adriana Valderrama, et al.
Advances in Therapy|December 3, 2013
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapySarah Thayer, Wenhui Wei, Erin Buysman, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Ecology and Evolution|June 30, 2021
Looking for the needle in a downsized haystack: Whole-exome sequencing unravels genomic signals of climatic adaptation in Douglas-fir (<i>Pseudotsuga menziesii</i>)Jan-Peter George, Silvio Schueler, Michael Grabner, et al.
Journal of Managed Care & Specialty Pharmacy|November 1, 2022
Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United StatesLia N Pizzicato, Aisha Vadhariya, Julie Birt, et al.
Primary Care Diabetes|November 5, 2017
Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitusSamaneh Kalirai, Judith Stephenson, Magaly Perez-Nieves, et al.
The New Phytologist|April 23, 2009
Three centuries of insect outbreaks across the European AlpsUlf Büntgen, David Frank, Andrew Liebhold, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
Current Medical Research and Opinion|April 17, 2015
Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) studyEllen B Dennehy, Rebecca L Robinson, Judith J Stephenson, et al.
Clinical Rheumatology|June 7, 2022
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USATheresa Hunter, Michael Grabner, Julie Birt, et al.
Future Oncology (London, England)|August 19, 2024
Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USALiya Wang, Mukul Singhal, Adriana Valderrama, et al.
Advances in Therapy|December 3, 2013
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapySarah Thayer, Wenhui Wei, Erin Buysman, et al.
Pageof 9